Lung cancer is still the leading cause of cancer-related mortality worldwide. In addition to established risk factors such as tobacco consumption and molecular alterations, the interaction between tumors and the nervous system is increasingly coming into focus. Recent data show that neurobiological mechanisms contribute significantly to the development, progression and treatment response of lung cancer. A comprehensive review in Cancer Letters summarizes the current findings and opens up new perspectives for diagnostics and therapy.
Autoren
- Tanja Schliebe
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- An emerging interface with clinical relevance
Lung cancer and neuroscience
- Acute leukemia: Disease management
Priorities from the perspective of patients and family caregivers
- Bronchodilators for asthma
The early bird … gasps for air
- Chronic kidney disease (CKD)
Triage of high-risk patients – Update 2025
- AAD Annual Meeting: Review
HS and acne – what’s new?
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies